Publications
Print PDF
Navigating Biosimilar Approvals: Start Conversations Early, Says IP Lawyer
January 5, 2016
Melissa Fassbender
BioPharma-Reporter.com

Axinn counsel Stacie Ropka was quoted in the BioPharma-Reporter.com article, "Navigating Biosimilar Approvals: Start Conversations Early, Says IP Lawyer."

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.